Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Parr YA"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax FIV).
Autorzy:
Westman M; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia.
Yang D; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia.
Green J; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia.
Norris J; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia.
Malik R; Centre for Veterinary Education, The University of Sydney, Sydney, NSW 2006, Australia.
Parr YA; MRC, University of Glasgow Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, UK.
McDonald M; Veterinary Diagnostic Services, The University of Glasgow, Glasgow G61 1QH, UK.
Hosie MJ; MRC, University of Glasgow Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, UK.
VandeWoude S; 1619 Campus Delivery, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Miller C; College of Veterinary Medicine, Oklahoma State University, 250 McElroy Hall, Stillwater, OK 74078, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Mar 12; Vol. 13 (3). Date of Electronic Publication: 2021 Mar 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Viral Vaccines*/administration & dosage
Viral Vaccines*/immunology
Cats/*immunology
Feline Acquired Immunodeficiency Syndrome/*prevention & control
Vaccination/*veterinary
Animals ; Antibodies, Viral/blood ; Female ; Immunodeficiency Virus, Feline ; Male ; Vaccines, Inactivated/administration & dosage ; Vaccines, Inactivated/immunology
Czasopismo naukowe
Tytuł:
Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus.
Autorzy:
Parr YA; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.
Beall MJ; IDEXX Laboratories, Inc.-Westbrook, ME 04092, USA.
Levy JK; Maddie's Shelter Medicine Program, University of Florida, Gainesville, FL 32608, USA.
McDonald M; Veterinary Diagnostic Services, University of Glasgow, Glasgow, Scotland G61 1QH, UK.
Hamman NT; Austin Pets Alive!, Austin, TX 78703, USA.
Willett BJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.
Hosie MJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Mar 07; Vol. 13 (3). Date of Electronic Publication: 2021 Mar 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Immunity, Humoral/*immunology
Leukemia Virus, Feline/*immunology
Leukemia, Feline/*diagnosis
Tumor Virus Infections/*veterinary
Animals ; Capsid Proteins/analysis ; Capsid Proteins/immunology ; Cats ; Enzyme-Linked Immunosorbent Assay ; Leukemia Virus, Feline/genetics ; Leukemia, Feline/immunology ; Leukemia, Feline/virology ; Proviruses/genetics ; Tumor Virus Infections/diagnosis ; Viral Load/veterinary ; Viral Proteins/immunology
Czasopismo naukowe
Tytuł:
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
Autorzy:
Rihn SJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Merits A; Institute of Technology, University of Tartu, Tartu, Estonia.
Bakshi S; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Turnbull ML; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Wickenhagen A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Alexander AJT; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Baillie C; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Brennan B; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Brown F; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Brunker K; Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, United Kingdom.
Bryden SR; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Burness KA; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Carmichael S; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Cole SJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Cowton VM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Davies P; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Davis C; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
De Lorenzo G; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Donald CL; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Dorward M; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Dunlop JI; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Elliott M; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Fares M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Freitas JR; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Furnon W; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Gestuveo RJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.; Division of Biological Sciences, College of Arts and Sciences, University of the Philippines Visayas, Miagao, Iloilo, Philippines.
Geyer A; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Giesel D; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Goldfarb DM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Goodman N; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Gunson R; West of Scotland Specialist Virology Centre, Glasgow, United Kingdom.
Hastie CJ; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Herder V; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Hughes J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Johnson C; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Johnson N; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Kohl A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Kerr K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Leech H; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Lello LS; Institute of Technology, University of Tartu, Tartu, Estonia.
Li K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Lieber G; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Liu X; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Lingala R; Indian Immunologicals Ltd (IIL), Rakshapuram, Gachibowli Post, Hyderabad Telangana, India.
Loney C; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Mair D; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
McElwee MJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
McFarlane S; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Nichols J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Nomikou K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Orr A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Orton RJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Palmarini M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Parr YA; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Pinto RM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Raggett S; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Reid E; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Robertson DL; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Royle J; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Cameron-Ruiz N; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Shepherd JG; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Smollett K; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Stewart DG; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Stewart M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Sugrue E; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Szemiel AM; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Taggart A; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Thomson EC; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Tong L; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Torrie LS; Drug Discovery Unit (DDU), Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Toth R; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Varjak M; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Wang S; Institute of Technology, University of Tartu, Tartu, Estonia.
Wilkinson SG; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Wyatt PG; Drug Discovery Unit (DDU), Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Zusinaite E; Institute of Technology, University of Tartu, Tartu, Estonia.
Alessi DR; MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Patel AH; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Zaid A; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.; School of Medical Sciences, Griffith University, Gold Coast, Queensland, Australia.
Wilson SJ; MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, United Kingdom.
Mahalingam S; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2021 Feb 25; Vol. 19 (2), pp. e3001091. Date of Electronic Publication: 2021 Feb 25 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Vaccines*
Reverse Genetics*
COVID-19/*diagnosis
COVID-19/*virology
SARS-CoV-2/*genetics
A549 Cells ; Angiotensin-Converting Enzyme 2/metabolism ; Animals ; Chlorocebus aethiops ; Codon ; Humans ; Hydrazones/pharmacology ; Mice ; Morpholines/pharmacology ; Open Reading Frames ; Plasmids/genetics ; Pyrimidines/pharmacology ; Serine Endopeptidases/metabolism ; Vero Cells ; Viral Proteins/metabolism
Czasopismo naukowe
Tytuł:
Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax 5).
Autorzy:
Westman M; Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia.
Norris J; Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia.
Malik R; Centre for Veterinary Education, The University of Sydney, Camperdown, NSW 2006, Australia.
Hofmann-Lehmann R; Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, The University of Zurich, CH-8057 Zürich, Switzerland.
Parr YA; MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK.
Armstrong E; MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK.
McDonald M; Veterinary Diagnostic Services, The University of Glasgow, Glasgow G61 1QH, UK.
Hall E; Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia.
Sheehy P; Sydney School of Veterinary Science, The University of Sydney, Camperdown, NSW 2006, Australia.
Hosie MJ; MRC-University of Glasgow Centre for Virus Research, Garscube Campus, Bearsden Road, Glasgow G61 1QH, UK.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Feb 03; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 03.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia Virus, Feline/*immunology
Leukemia, Feline/*prevention & control
Vaccination/*veterinary
Viral Vaccines/*administration & dosage
Animals ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Australia ; Cats ; Enzyme-Linked Immunosorbent Assay ; Gene Products, gag/immunology ; Leukemia Virus, Feline/genetics ; Leukemia Virus, Feline/isolation & purification ; Leukemia, Feline/diagnosis ; Vaccines, Inactivated/administration & dosage
Czasopismo naukowe
Tytuł:
Absence of adaptive evolution is the main barrier against influenza emergence in horses in Asia despite frequent virus interspecies transmission from wild birds.
Autorzy:
Zhu H; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Damdinjav B; State Central Veterinary Laboratory, Transboundary Animal Disease Laboratory, Avian Influenza Section, Ulaanbaatar, Mongolia.
Gonzalez G; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Patrono LV; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.; Project Group Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
Ramirez-Mendoza H; Departamento de Microbiología e Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad de Mexico, México.
Amat JAR; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Crispell J; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Parr YA; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Hammond TA; Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, United Kingdom.
Shiilegdamba E; Wildlife Conservation Society, Bronx, NY, United States of America.
Leung YHC; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Laboratory Animal Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Peiris M; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Marshall JF; Weipers Centre Equine Hospital, School of Veterinary Medicine, University of Glasgow, Glasgow, United Kingdom.
Hughes J; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Gilbert M; Wildlife Conservation Society, Bronx, NY, United States of America.; Boyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.; Department of Population Medicine and Diagnostic Science, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States of America.
Murcia PR; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2019 Feb 07; Vol. 15 (2), pp. e1007531. Date of Electronic Publication: 2019 Feb 07 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Horses/*immunology
Influenza in Birds/*genetics
Animals ; Animals, Wild ; Asia ; Biological Evolution ; Birds ; Disease Outbreaks ; Disease Transmission, Infectious/veterinary ; Evolution, Molecular ; Horses/genetics ; Humans ; Influenza in Birds/immunology ; Influenza, Human ; Orthomyxoviridae Infections/veterinary ; Phylogeny
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies